Muraglitazar Completed Phase 3 Trials for Metabolics Diabetes Nos Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00162175PPAR-COMBO With Sulfonylurea